Acceleron Pharma, Inc. (XLRN)

Check out top investors' recommendation for XLRN
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
78.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Yaron Werber Citi Buy   Oct 13, '19     78.00  Oct 13, '20  N/A 
Yaron Werber Citi Buy   Jun 16, '19     78.00  Jun 16, '20  N/A 
Yaron Werber Citi Buy   Feb 25, '19     78.00  Feb 25, '20  N/A 
Edward Tenthoff Piper Jaffray Buy   Sep 17, '18       Sep 17, '19  N/A 
Edward Tenthoff Piper Jaffray Buy   Feb 28, '18     53.00  Feb 28, '19  N/A 
Geoff Meacham JPMorgan Buy   Feb 28, '18     54.00  Feb 28, '19  N/A 
Alethia Young Deutsche Bank Securities Buy   Jan 17, '18     55.00  Jan 17, '19  N/A 
Alethia Young Deutsche Bank Securities Buy   Nov 14, '17     51.00  Nov 14, '18  N/A 
Edward Tenthoff Piper Jaffray Buy   Oct 06, '17     40.00  Oct 06, '18  N/A 
Alethia Young Deutsche Bank Securities Buy   Aug 04, '17     35.00  Aug 04, '18  N/A 
Robyn Karnauskas Deutsche Bank Securities Buy   Aug 04, '17     44.00  Aug 04, '18  N/A 
Edward Tenthoff Piper Jaffray Buy   Jun 26, '17     40.00  Jun 26, '18  N/A 
Terence Flynn Goldman Sachs Sell   May 17, '17     20.00  May 17, '18  N/A 
Yaron Werber Citi Buy   Mar 02, '17     36.00  Mar 02, '18  N/A 
Gerardo Torculas Unaffiliated Buy   Aug 26, '16   30.21  33.00  Sep 26, '16  30.75% 
Edward Tenthoff Piper Jaffray Buy   Feb 25, '16   24.18  37.00  Feb 25, '17  53.02% 
Ling Wang Summer Street Research Buy   Feb 01, '16   30.77  58.00  Feb 01, '17  -21.09% 
Ling Wang Summer Street Research Buy   Dec 07, '15   42.88  58.00  Dec 07, '16  -20.76% 
Yaron Werber Citi Buy   Mar 03, '15   41.17  52.00  Mar 03, '16  -32.84%